Funding and Finance

Geneoscopy raises $105M for CRC, IBD test drive

By LabPulse.com staff writers

Geneoscopy has raised $105 million in a Series C funding round led by Bio-Rad Laboratories.

January 8, 2025

Galapagos to split into separate companies, lay off staff

By LabPulse.com staff writers

Pharmaceutical firm Galapagos will split into two separate companies in a restructuring that will lay off 300 employees and make changes to a major licensing agreement with Gilead.

January 8, 2025

Sysmex America, DiaCarta highlight FIT CRC screening tests

By LabPulse.com staff writers

Developments that may signal increased fecal immunochemical testing in colorectal cancer screening worldwide in 2025.

January 6, 2025

Labcorp, UHS settle False Claims Act testing allegations

By LabPulse.com staff writers

Labcorp and University Health System (UHS) have collectively agreed to pay nearly $389,000 to settle allegations that they violated the False Claims Act by delaying the submission of physician orders for lab tests to improperly bill Medicare.

January 6, 2025

Versant Diagnostics reports Avero Diagnostics partnership

By LabPulse.com staff writers

Versant Diagnostics has expanded its footprint in the Pacific Northwest through partnership affiliation with Avero Diagnostics in Bellingham, WA.

January 2, 2025

BioNTech reaches agreement with NIH, Penn on COVID-19 vaccine royalties

By LabPulse.com staff writers

German company BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health (NIH) and the University of Pennsylvania (Penn) over royalty payments for its COVID-19 vaccine.

December 27, 2024

GemmaBio raises $34M in seed funding

By LabPulse.com staff writers

Newly-formed therapeutics firm Gemma Biotherapeutics (GemmaBio) has completed a $34 million financing round.

December 26, 2024

U.S. District Court grants 10x Genomics injunction against NanoString

By LabPulse.com staff writers

The U.S. District Court for the District of Delaware awarded 10x Genomics a permanent injunction against GeoMx products produced by NanoString Technologies, a subsidiary of Bruker Corporation.

December 26, 2024

Singular Genomics agrees to Deerfield acquisition for $20 in cash per share

By LabPulse.com staff writers

Singular Genomics has made a definitive merger agreement in which an affiliate of Deerfield Management Company will acquire Singular Genomics in an all-cash transaction for $20 per share.

December 23, 2024

BD, Babson Diagnostics expand fingertip blood testing program

By LabPulse.com staff writers

Becton Dickson (BD) and Babson Diagnostics have announced an expansion in their collaborative BetterWay blood collection and testing program.

December 17, 2024

AstraZeneca, Tracer Biotechnologies sign cancer monitoring project agreement

By LabPulse.com staff writers

Tracer Biotechnologies and AstraZeneca have announced an agreement on a multi-year project in which AstraZeneca will use Tracer's circulating tumor DNA (ctDNA) monitoring technology for clinical trials.

December 18, 2024

Labcorp to acquire MAWD Pathology Group assets

By LabPulse.com staff writers

Labcorp has agreed to acquire select assets of MAWD Pathology Group's clinical and women's health testing businesses.

December 16, 2024

Page 1 of 144

Next Page